Aims/Background-Uveitis, an intraocular inflammatory disease, is a significant cause of visual impairment. It is not known how many patients with uveitis will retain visual acuity and how many develop visual impairment or even blindness. The aim of this study was to assess the frequency of blindness in patients with uveitis and, more specifically, to identify the clinical profile of patients at risk for visual loss. Methods-A cross sectional and retrospective study of 582 patients with uveitis who visited the ophthalmology departments of two university hospitals in the Netherlands was performed.
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Aims/Background-Uveitis, an intraocular inflammatory disease, is a significant cause of visual impairment. It is not known how many patients with uveitis will retain visual acuity and how many develop visual impairment or even blindness. The aim of this study was to assess the frequency of blindness in patients with uveitis and, more specifically, to identify the clinical profile of patients at risk for visual loss. Methods-A cross sectional and retrospective study of 582 patients with uveitis who visited the ophthalmology departments of two university hospitals in the Netherlands was performed. Results-Within the group of 582 patients, 203 (35%) exhibited blindness or visual impairment; bilateral legal blindness developed in 22 (4%) patients, 26 (4.5%) had one blind eye with visual impairment of the other, and nine (10/5%) had bilateral visual impairment. Unilateral blindness developed in 82 (14%) patients, whereas 64 (11%) exhibited unilateral visual impairment. The most important cause of both blindness and visual impairment was cystoid macular oedema (29% and 41%, respectively). Complications of uveitis were encountered in more than half of the patients and 23% underwent one or more surgical procedures. When the patients were subdivided according to anatomical site, those with panuveitis had the worst visual prognosis. The systemic diseases associated with a poor visual prognosis were juvenile chronic arthritis and sarcoidosis. Ocular toxoplasmosis was the most frequent cause of unilateral visual loss. Conclusions-Cystoid macular oedema is the most frequent complication of uveitis and its occurrence plays a decisive role in the visual outcome of this disease. (BrJ Ophthalmol 1996; 80: 332-336) Uveitis, an intraocular inflammatory disease, is a major cause of severe visual impairment. The number of patients blind as a result of uveitis is unknown; it has been estimated that uveitis accounts for 10% to 15% of all cases of total blindness in the United States.' The decrease in visual acuity may be attributable to cataract formation, secondary glaucoma, vitreous opacities, cystoid macular oedema, retinal scars, and other causes.2 The prevalence of uveitis reported in 1984 was 38 per 100 000 in a general population: the annual incidence was approximately 17 per 100 000 with maximum incidence in the 25 to 44 year age group.3 In surveys of the causes of blindness uveitis is usually not included and is probably underestimated. The sequelae of uveitis are considered to be the direct cause of visual loss (for example, cataract, glaucoma) while the primary cause of the decrease in visual acuity (uveitis) is not mentioned. In a recent hospital based survey of blindness in West Africa, in which these sequelae were correctly attributed to uveitis, this disease was the second leading cause of blindness; this indicates how large the proportion of patients with uveitis is among the blind. 4 In the Netherlands (1975-7), in a hospital based study, uveitis caused 6% of all blindness and ranked fifth after diabetic retinopathy, age-related macular degeneration, tapetoretinal dystrophy, and glaucoma.5 In the 1993 annual report of Research to Prevent Blindness, an estimated 2 300 000 Americans suffer visual impairment because of this major sight robbing disease. 6 It is not known how many patients with uveitis retain useful visual acuity and how many develop a visual handicap or even blindness. We therefore performed a retrospective study of 582 patients with uveitis of various origins to assess the frequency of blindness and visual handicap in that population and, more specifically, to identify the clinical profile of uveitis patients at risk for visual impairment.
Subjects and methods
The study included 280 consecutive patients with uveitis who visited the ophthalmology department of the University Hospital in Utrecht during 1993 and were followed for more than 1 year and 302 patients with uveitis followed for more than 1 year and chosen at random (numeric code) from the data bank of patients from the Academic Medical Centre in Amsterdam. Both institutions combine secondary and tertiary ophthalmological care; patients are referred by ophthalmologists from a large area and also by general practitioners from a smaller local area. When the patients from the two study locations were compared, their general characteristics such as male to female ratio, unilateral or bilateral involvement, site of the inflammation, tertiary referral, and duration of follow up did not differ significantly (p>0 05). The majority of patients were referred by an ophthalmologist (358; 61%); 127 (22%) were referred by their primary health care physician and occasional patients were referred by the emergency department or other (nonophthalmological) specialists within the hospital itself. The mean follow up period was 4-3 years.
Causes andfrequency ofblindness in patients with intraocular inflammatory disease The following data were recorded: sex and age of the patients, age at the onset of uveitis, referring physician, anatomical site and aetiological agent of uveitis, eventual associations with systemic diseases, all complications of uveitis and the subsequent treatment, and maximum visual acuity at the end of follow up.
Legal blindness was defined as a best corrected visual acuity of less than 0 1 for the better eye.'3 This corresponds to the standard WHO definitions of severe visual impairment (equal to or better than 20/400 but less than 20/200) and blindness (from no light perception to 20/400).14 The criterion for visual impairment was a best corrected visual acuity equal to or less than 0 3 for the eye with better vision. To determine the visual loss, the final visual acuity was used and not the worst visual acuity at any visit. In patients with more than one complication, the cause of visual loss was attributed to the first complication which caused the final blindness or visual impairment (for example, first, toxoplasmic macular lesion followed by retinal detachment). Visual loss due to other causes which were not related to uveitis (for example, amblyopia) was not included in the final evaluation. However, the complications from the treatment for uveitis (for example, steroid induced cataract) were included.
Glaucoma was considered in the eyes with the combination of elevated intraocular pressure and visual field defects and not in cases with ocular hypertension only. The visual field loss from glaucoma resulting in less than 10 degree field was considered one of the criteria of legal blindness.
Cystoid macular oedema was defined by both clinical and angiographic criteria. Angiographic evidence was required in all cases where the cause of legal blindness of visual impairment was attributed to macular oedema.
We used the x2 test for statistical analysis. A p value of less than 0 01 was considered significant.
Results
Within the group of 582 patients, 203 (35%) suffered from significant visual loss: bilateral legal blindness developed in 22 (4%), 26 (4-5%) had one blind eye with visual impairment of the other, and nine (1 5%) had bilateral visual impairment ( The most frequent systemic disorders associated with uveitis were sarcoidosis (n= 56; 10%) and ankylosing spondylitis (n=20; 3A4%; an additional 43 patients had HIA B27 associated acute anterior uveitis without ankylosing spondylitis); the most common ocular disease was ocular toxoplasmosis (n=60; 10%; Table  4 ). The frequency of bilateral blindness and visual impairment among patients with uveitis of unknown aetiology did not differ significantly from that found for uveitis of known aetiology (blindness 5 5% versus 2 9%, p=0 1; visual impairment 7T5% versus 5-2%, p=0 3; Table 4 ).
Bilateral visual blindness or impairment occurred in uveitis of unknown origin in 42% (24/57) and 14% (8/57) of bilaterally blind patients had uveitis associated with (histologically confirmed) sarcoidosis (Tables 1 and 4) . Uveitis in juvenile chronic arthritis had the worst visual prognosis; five out of eight patients suffered bilateral visual impairment or blindness. Of the 63 patients with HIA B27 associated acute anterior uveitis, none exhibited bilateral visual loss; there were three cases of unilateral blindness and three of unilateral impairment. Ocular toxoplasmosis was the most frequent cause of both unilateral legal blindness and unilateral visual impairment; this was attributed to the site of the retinal inflammatory lesion in the macula. None of the 60 patients with ocular toxoplasmosis experienced bilateral loss of vision. None of five patients with Behiet's disease was bilaterally blind; however, three developed unilateral blindness.
Discussion
Within the group of 582 patients, 203 (35%) developed blind or visually impaired eyes. Bilateral loss of visual acuity developed in 10% and unilateral loss of vision occurred in an additional 25% of all patients with uveitis. The principal mechanism of visual loss in uveitis was cystoid macular oedema.
In the Netherlands, the patient is referred for either diagnostic or therapeutic help in the event of recurrent, chronic, or very severe acute uveitis. Acute cases which respond favourably to therapy are usually not referred. Although the results from two centres included did not differ significantly, the variability in timing of referral and the treatment given may have influenced the overall outcome and the findings should be interpreted with caution. The retrospective character of this study did not allow the clinically relevant evaluation of the relation between the therapy data and visual prognosis. 25 The comparison of our data on the less frequent types of uveitis with previously published reports on one disease entity is very difficult. The poor visual prognosis for acute retinal necrosis, juvenile chronic arthritis, and serpiginous chorioretinopathy noted even for the small numbers of patients in our study was known from previous publications.2629 All patients with acute retinal necrosis (n= 6) developed visual loss ( We conclude that cystoid macular oedema was the most frequent complication among patients with uveitis and its occurrence played a decisive role in the visual outcome. The best treatment for uveitic macular oedema has yet to be identified. 40 The timing of eventual treatment of macular oedema in uveitis patients is difficult, because the loss of visual acuity is gradual and therapy may induce many systemic and ocular complications. Therefore, treatment is usually not initiated until late in the disease process but then the reversible stage of the disease may already have passed.41
The causes of blindness in the western World are probably changing as a result of recent advances in diagnosis and therapy of ocular and systemic diseases, epidemiological changes, and other factors. As a consequence there may be a growing impact of uveitis on blindness, especially in the younger age groups. Recent surveys of the causes of blindness which focus not only on the ocular features but also on the underlying primary conditions, such as uveitis, are needed.
